Finasteride Vs Exosome Therapy: How They Compare For Hair Loss
Last reviewed on 1 October 2026. We review our treatment guides every six months to keep them accurate.
Key points
They work in completely different ways. Finasteride is a daily tablet that lowers the hormone (DHT) driving male pattern hair loss, so it treats the cause. Exosome therapy is an in-clinic injection of lab-grown "messenger" packets that stimulate the follicles, but does nothing to the hormone.
So they are not really rivals. Because one tackles the cause and the other stimulates the follicles, they act at different points rather than being a straight either-or choice.
Finasteride is a proven, first-line treatment. It is a licensed, well-established medicine for male pattern hair loss that reliably lowers the DHT behind the loss, and it is especially good at stopping or slowing further thinning.
The evidence gap is large. Finasteride has strong, long-standing evidence; exosome therapy is backed mostly by laboratory work, with only early clinical data in people, and it is not standardised or approved.
Cost points the same way. Finasteride is a cheap daily tablet; exosome therapy is an expensive course of clinic injections.
Neither adds hair or restores a bald scalp. Both work on hair that is still there, so neither can regrow a genuinely bald area, and for that a hair transplant is the only option that adds hair.
Both are ongoing commitments, and exosome therapy is often added on top of a proven treatment rather than used instead of one. Which suits you is best decided with a clinician.
Finasteride and exosome therapy are two very different options for male pattern hair loss: one is a proven, first-line hormone-lowering tablet, the other a newer, expensive, lab-derived injection whose evidence is still early. Because they work in different ways, comparing them is less about which is "better" and more about understanding what each one does, but on the evidence the two are far apart.
This guide compares finasteride and exosome therapy neutrally: what each is, how they differ, how effective they are, what they cost you in commitment and money, who each suits, and how they fit together. It is general information and not a substitute for advice from a doctor.
The short answer
Finasteride and exosome therapy target hair loss at different points, and on the evidence they are a long way apart. Finasteride is a drug that lowers DHT, the hormone that causes male pattern loss, so it treats the underlying cause, is a proven first-line treatment and is cheap, and it is especially good at holding on to hair. Exosome therapy is an in-clinic injection of lab-grown signalling packets that stimulate the follicles you still have, without touching the hormone; it is promising in theory but backed mostly by laboratory studies, is not standardised or approved, and is expensive. If you had to choose one, finasteride is the far better-evidenced and cheaper option for tackling the cause; exosome therapy is a newer, unproven, costly choice, of interest mainly to those who cannot take a DHT drug or want to add an experimental clinic treatment. Neither, though, can regrow a scalp that is already bald.
What is finasteride?
Finasteride is a daily tablet that treats male pattern hair loss by lowering DHT, the hormone that shrinks genetically sensitive follicles. It blocks the enzyme 5-alpha reductase, which, as a review of these drugs in dermatology explains, "converts testosterone to dihydrotestosterone (DHT), which amplifies androgen effects in certain tissues". By blocking it, finasteride produces "a substantial reduction in serum (around 70%)" DHT, and the review notes that "long-term use of finasteride at a 1-mg dose proved to be safe and effective in treating male-pattern" hair loss. It works on the cause of the loss rather than just the symptoms, which is why it is a first-line treatment, and it is licensed for male pattern hair loss. Our guide on finasteride for hair loss covers it in detail, including the possible side effects.
What is exosome therapy?
Exosomes are tiny "messenger" packets that cells use to send signals to one another. In hair treatments they are usually grown in a laboratory from stem cells and then injected into the scalp to deliver those signals to the follicles. As a review of exosomes in hair loss explains, they are "nanosized extracellular vesicles rich in proteins, nucleic acids, and lipids" that "modulate the hair follicle microenvironment through activation of Wnt/beta-catenin signaling, promotion of angiogenesis, immunomodulation, and prolongation of the anagen phase", the active growth phase of the hair cycle. In other words, exosomes carry a broad, targeted payload of growth signals, which is why there is so much interest in them. The catch is that, unlike finasteride, they do not treat the hormonal cause, the treatment is new and not standardised, and it is expensive. Our guide on exosome therapy for hair loss explains it further.
Which is more effective for hair loss?
For tackling the cause of male pattern loss, finasteride is the far more proven and better-evidenced option. It is a first-line medicine that reliably lowers the DHT driving the loss, and it is especially effective at stopping or slowing further thinning. Exosome therapy is much earlier: a systematic review of exosome treatment in hair restoration identified only "16 studies (15 preclinical and 1 clinical)", meaning almost all the evidence so far comes from the laboratory rather than from trials in people.
The early human signal for exosomes is encouraging, though. In that single clinical study, the review noted, "topical ADSC-Exo has been tried successfully in 39 androgenetic alopecia patients demonstrating significant increases in hair density and thickness", and "no significant adverse reactions associated with exosome treatment...reported thus far", concluding that "although current clinical evidence supporting the use of exosome treatment is limited, there is a growing body of evidence suggesting its therapeutic potential". The more useful point, though, is that they are not really measuring the same thing: finasteride cuts the hormone at source with strong evidence, while exosome therapy stimulates the follicles with a treatment that is still largely experimental. So on the current evidence finasteride is clearly the more proven, while exosome therapy is promising but not yet established.
Finasteride vs exosome therapy: how do they compare?
The two are very different in almost every practical way:
What they are: finasteride is a daily prescription tablet (a drug); exosome therapy is a course of in-clinic injections of lab-grown signalling packets (a procedure).
How they work: finasteride lowers DHT, the hormonal cause of male pattern loss; exosomes deliver growth signals to stimulate the follicles but do not affect DHT.
What they are best at: finasteride is best at stopping or slowing further loss; exosome therapy is aimed at boosting the follicles you still have.
Evidence and status: finasteride is first-line, licensed and backed by strong, long-standing evidence; exosome therapy is backed mostly by laboratory work, with only early clinical data, and is not standardised or approved.
Cost: finasteride is a cheap daily tablet; exosome therapy is a far more expensive course of clinic injections with maintenance top-ups.
Drug or procedure: finasteride is a hormonal medicine that can cause side effects in a minority; exosome therapy is a clinic injection with no significant adverse reactions reported so far but limited long-term data.
What neither does: neither adds new hair or restores a bald area, so both are for keeping and supporting the hair you still have rather than replacing hair that is gone.
Which is right for you?
If your aim is to tackle male pattern loss at its source with the best-evidenced option, finasteride is the logical starting point and the stronger choice by a wide margin, because it treats the cause, is proven and licensed, is cheap, and is particularly good at holding on to your hair. Exosome therapy is a choice mainly for those who cannot or would prefer not to take a DHT-lowering drug, or who want to add a clinic-based treatment, provided they accept that its human evidence is still early, it is not standardised, and it costs a great deal more. Neither, though, suits someone whose loss is advanced or whose follicles are already gone, because both only work on hair that is still there.
Because finasteride is a prescription medicine and exosome products are not standardised and are expensive, it is worth discussing either with a clinician, who can weigh up your pattern of loss, your preferences about medication, and whether an experimental injectable adds anything for you when a proven, cheap option exists.
Can they be combined with other treatments?
Yes, and in practice exosome therapy is best thought of as an add-on to a proven base rather than a treatment on its own. Because finasteride treats the cause and exosomes stimulate the follicles, the two could in principle be used together, with the DHT-lowering tablet doing the heavy lifting and the injection added on top. Finasteride is also commonly paired with minoxidil, a topical growth stimulant, which we compare in our guide on finasteride versus minoxidil; and exosome therapy sits within the wider regenerative space, compared with PRP in our guide on PRP versus exosomes.
Neither can restore hair that is already gone. Where loss is more advanced, a hair transplant is a separate option that redistributes your own permanent hair, and both a DHT-lowering tablet and a regenerative treatment are sometimes used around a transplant to protect and support the result; our guides on finasteride versus PRP and hair transplant versus PRP look at how these fit together. The key point is that finasteride and exosome therapy are usually part of a wider plan, with the proven treatment the foundation.
The bottom line
Finasteride and exosome therapy are very different tools that work at different points in male pattern hair loss, and on the evidence they are far apart. Finasteride is a cheap daily tablet that lowers DHT and treats the cause, with strong first-line evidence and a particular strength in stopping further loss. Exosome therapy is an expensive, in-clinic, lab-derived injection that stimulates the follicles but does not touch the hormone, and is promising in theory but backed mostly by early evidence and is not standardised or approved. Neither adds hair or restores a bald area.
If you had to choose one, finasteride has far the stronger evidence and tackles the root of the problem, at a fraction of the cost, while exosome therapy is a newer, unproven option best seen as a possible add-on for those who cannot take a DHT drug. A clinician can help you decide which, or whether a combination, suits your hair loss, and how it might fit alongside other treatments or a hair transplant.
Frequently asked questions
Is finasteride or exosome therapy better for hair loss?
For tackling the cause of male pattern loss, finasteride is the far more proven and far cheaper option, because it is a first-line, licensed medicine that lowers the DHT that causes the loss. Exosome therapy carries a richer mix of growth signals and could in theory help, but its human evidence is still early, with only one clinical study in a recent review, and it is expensive. So finasteride is clearly the better-evidenced choice for the cause, while exosome therapy is a newer, unproven option best seen as a possible add-on.
What is the difference between finasteride and exosome therapy?
Finasteride is a daily tablet, a drug that lowers DHT, the hormone behind male pattern hair loss, so it treats the underlying cause. Exosome therapy is an in-clinic injection of tiny signalling packets grown in a laboratory from stem cells, which stimulate the follicles without changing your hormones. So finasteride works on the cause from the inside, while exosome therapy supports the follicles from the outside; one is a cheap, proven everyday medicine, the other a newer, expensive clinic injection.
Can you use finasteride and exosome therapy together?
In principle yes, and if exosome therapy is used it is best as an add-on to a proven base rather than instead of one. Because finasteride treats the hormonal cause and exosomes stimulate the follicles, the two work at different points, so a DHT-lowering tablet can do the main work while an injection is added on top. Combining treatments is a decision to make with a clinician, who can advise whether an experimental injectable adds anything worthwhile for your pattern of loss when a proven, cheap option already exists.
Do finasteride or exosome therapy regrow hair on a bald scalp?
No. Both work on follicles that are still present: finasteride by cutting the hormone that shrinks them, exosome therapy by stimulating them. Neither can grow hair where the follicles have already been lost, so neither will restore a genuinely bald or fully receded area. For that, a hair transplant is the only option that adds hair to bare scalp. Finasteride and exosome therapy are best used earlier, to keep and support the hair you still have, rather than as a cure for baldness.
Get back to Great Hair
in 3 Easy Steps:
01
Arrange Free Consultation
Speak to one of our specialist consultants for expert advice on our range of different hair loss treatments
02
Book Your Procedure
Place a deposit to reserve a time slot at one of the My Hair UK clinics across the UK
03
Attend Your Surgery
Arrive on the day and our specialist surgical team will look after your every need
What People Say About Us
Read our independent My Hair UK Reviews on Reviews.io
The Surgical Team
The surgical team is what makes the difference on the day. The clinics’ five surgeons are all GMC-registered, with a minimum of 1,000 FUE hair transplant procedures each to their name. Between them the team handles complex cases, including Afro-textured and women’s hair transplants, hairline design and lowering, and revision work.
Manchester clinic
• Dr Khawaja Masood Munir: GMC 6122581.
8+ years’ experience, 1,400+ hair transplant surgeries.
• Dr Haider Gillani: GMC 8030796.
1,000+ procedures, with specific expertise in complex cases requiring detailed anatomical understanding.
London (Harrow) clinic
• Dr Mahdi Alosert: GMC 6168297.
20+ years’ clinical experience. Specialist in Afro-Caribbean hair and hairline lowering.
• Dr Shuaib Mir: GMC 7567898.
1,200+ hair transplant cases. BAAPS plastic surgery and RCS anatomy training.
• Dr Zakar Rafiq: GMC 6164032.
MBBS and BSc (Hons) from Imperial College London. Associate Member of the International Society of Hair Restoration Surgery (ISHRS).
You can meet the surgeon who will perform your procedure at your free consultation.